A New Primaquine Analogue, Tafenoquine (WR 238605), for Prophylaxis againstPlasmodium falciparumMalaria
Open Access
- 15 December 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (12) , 1968-1974
Abstract
We tested tafenoquine (WR 238605), a new long-acting 8-aminoquinoline, for its ability to prevent malaria in an area that is holoendemic for PlasmodiKeywords
This publication has 12 references indexed in Scilit:
- Malaria chemoprophylaxis with tafenoquine: a randomised studyThe Lancet, 2000
- Randomized Dose‐Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse ofPlasmodium vivaxMalaria in ThailandThe Journal of Infectious Diseases, 1999
- Prophylaxis of Plasmodium falciparum Infection in a Human Challenge Model with WR 238605, a New 8-Aminoquinoline AntimalarialAntimicrobial Agents and Chemotherapy, 1998
- First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.The American Journal of Tropical Medicine and Hygiene, 1998
- Successful Double‐Blinded, Randomized, Placebo‐Controlled Field Trial of Azithromycin and Doxycycline as Prophylaxis for Malaria in Western KenyaClinical Infectious Diseases, 1998
- Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malariaThe Lancet, 1995
- G6PD deficiencyBlood, 1994
- Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East AfricaThe Lancet, 1993
- The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605Pathogens and Global Health, 1993
- DOXYCYCLINE PROPHYLAXIS FOR FALCIPARUM MALARIAThe Lancet, 1987